<code id='33D1C219A3'></code><style id='33D1C219A3'></style>
    • <acronym id='33D1C219A3'></acronym>
      <center id='33D1C219A3'><center id='33D1C219A3'><tfoot id='33D1C219A3'></tfoot></center><abbr id='33D1C219A3'><dir id='33D1C219A3'><tfoot id='33D1C219A3'></tfoot><noframes id='33D1C219A3'>

    • <optgroup id='33D1C219A3'><strike id='33D1C219A3'><sup id='33D1C219A3'></sup></strike><code id='33D1C219A3'></code></optgroup>
        1. <b id='33D1C219A3'><label id='33D1C219A3'><select id='33D1C219A3'><dt id='33D1C219A3'><span id='33D1C219A3'></span></dt></select></label></b><u id='33D1C219A3'></u>
          <i id='33D1C219A3'><strike id='33D1C219A3'><tt id='33D1C219A3'><pre id='33D1C219A3'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:comprehensive    Page View:4336
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In